U.S. markets close in 3 hours 26 minutes
  • S&P 500

    4,057.03
    -19.54 (-0.48%)
     
  • Dow 30

    34,325.07
    -69.94 (-0.20%)
     
  • Nasdaq

    11,404.15
    -78.30 (-0.68%)
     
  • Russell 2000

    1,887.45
    +5.78 (+0.31%)
     
  • Crude Oil

    81.07
    -0.15 (-0.18%)
     
  • Gold

    1,809.50
    -5.70 (-0.31%)
     
  • Silver

    23.34
    +0.50 (+2.21%)
     
  • EUR/USD

    1.0533
    +0.0004 (+0.04%)
     
  • 10-Yr Bond

    3.5570
    +0.0280 (+0.79%)
     
  • GBP/USD

    1.2290
    +0.0033 (+0.27%)
     
  • USD/JPY

    134.6110
    -0.6950 (-0.51%)
     
  • BTC-USD

    16,961.18
    -19.61 (-0.12%)
     
  • CMC Crypto 200

    402.65
    +1.22 (+0.31%)
     
  • FTSE 100

    7,556.23
    -2.26 (-0.03%)
     
  • Nikkei 225

    27,777.90
    -448.18 (-1.59%)
     

Top Ranked Momentum Stocks to Buy for April 27th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 27th:

Avenue Therapeutics, Inc. (ATXI): This specialty pharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 28.6% over the last 60 days. 

Avenue Therapeutics, Inc. Price and Consensus

Avenue Therapeutics, Inc. Price and Consensus
Avenue Therapeutics, Inc. Price and Consensus

Avenue Therapeutics, Inc. price-consensus-chart | Avenue Therapeutics, Inc. Quote

Avenue Therapeutics’ shares gained 15.4% over the last one month above the S&P 500’s increase of 7.9%. The company possesses a Momentum Score of A.

Avenue Therapeutics, Inc. Price

Avenue Therapeutics, Inc. Price
Avenue Therapeutics, Inc. Price

Avenue Therapeutics, Inc. price | Avenue Therapeutics, Inc. Quote

Can-Fite BioPharma Ltd. (CANF): This clinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 19.9% over the last 60 days.

Can-Fite Biopharma Ltd Price and Consensus

Can-Fite Biopharma Ltd Price and Consensus
Can-Fite Biopharma Ltd Price and Consensus

Can-Fite Biopharma Ltd price-consensus-chart | Can-Fite Biopharma Ltd Quote

Can-Fite BioPharma’s shares gained 25.9% over the last one month. The company possesses a Momentum Score of A.

Can-Fite Biopharma Ltd Price

Can-Fite Biopharma Ltd Price
Can-Fite Biopharma Ltd Price

Can-Fite Biopharma Ltd price | Can-Fite Biopharma Ltd Quote

Gold Fields Limited (GFI): This gold producer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 45% over the last 60 days.

Gold Fields Limited Price and Consensus

Gold Fields Limited Price and Consensus
Gold Fields Limited Price and Consensus

Gold Fields Limited price-consensus-chart | Gold Fields Limited Quote

Gold Fields’ shares gained 41.5% over the last one month. The company possesses a Momentum Score of B.

Gold Fields Limited Price

Gold Fields Limited Price
Gold Fields Limited Price

Gold Fields Limited price | Gold Fields Limited Quote

Manning & Napier, Inc. (MN): This investment manager has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 41.2% over the last 60 days.

Manning & Napier, Inc. Price and Consensus

Manning & Napier, Inc. Price and Consensus
Manning & Napier, Inc. Price and Consensus

Manning & Napier, Inc. price-consensus-chart | Manning & Napier, Inc. Quote

Manning & Napier’s shares gained 159.8% over the last one month. The company possesses a Momentum Score of B.

Manning & Napier, Inc. Price

Manning & Napier, Inc. Price
Manning & Napier, Inc. Price

Manning & Napier, Inc. price | Manning & Napier, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Just Released: Zacks’ 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.1% per year.

These 7 were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Manning & Napier, Inc. (MN) : Free Stock Analysis Report
 
Gold Fields Limited (GFI) : Free Stock Analysis Report
 
Can-Fite Biopharma Ltd (CANF) : Free Stock Analysis Report
 
Avenue Therapeutics, Inc. (ATXI) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.